The research firm has a marketweight rating on GURU and does not rate ALFA.
ALFA and GURU are not the only guru ETFs boosting exposure to healthcare stocks. Earlier this month, the managers of the Validea Market Legends ETF (NasdaqGM: VALX), an actively managed exchange traded fund, that selects and scores stocks using proprietary models based on the approaches of famous investors such as Warren Buffett and Peter Lynch, said that ETF has increased its biotech and healthcare exposure. [Market Legends ETF ups Healthcare Exposure]
Validea added to VALX stakes in Dow component Merck (NYSE: MRK) and biotech giants Gilead Sciences (NasdaqGS: GILD) and Celgene (NasdaqGS: CELG).
Last week, it was reported that the Direxion iBillionaire Index ETF (NYSEArca: IBLN) has also increased its healthcare weight. Following its most recent rebalance, iBillionaire Inc.’s iBillionaire Index (BILLIONR), IBLN’s underlying benchmark, allocates 23.3% of its weight to healthcare stocks, tying the sector with technology as the index’s second largest sector weight. New additions to IBLN, include three healthcare names; Endo International (NasdaqGS: ENDP), Humana (NYSE: HUM) and McKesson (NYSE: MCK).
AlphaClone Alternative Alpha ETF
